Exelixis, Inc. (EXEL)

Healthcare · Biotechnology · NASDAQ

Exelixis, Inc. (EXEL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $13.40B, a trailing price-to-earnings ratio of 15.4 and a free-cash-flow yield of 5.5%. Over the most recent reported fiscal year, revenue grew 7.0% and free cash flow per share grew 40.0%.

Market cap	$13.40B
Trailing P/E	15.4
FCF yield	5.5%
Revenue growth (YoY)	+7.0%
EPS growth (YoY)	+52.2%
FCF/share growth (YoY)	+40.0%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live EXEL data on Nama Insights →

Recent Congressional trades

Exelixis, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Donna Shalala	House	Sell	$1,001 - $15,000	Jun 30, 2019
Donna Shalala	House	Buy	$1,001 - $15,000	Feb 28, 2019
Donna Shalala	House	Buy	$1,001 - $15,000	Jan 31, 2019